393 related articles for article (PubMed ID: 19648748)
1. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
Razay G; Williams J; King E; Smith AD; Wilcock G
Dement Geriatr Cogn Disord; 2009; 28(1):70-4. PubMed ID: 19648748
[TBL] [Abstract][Full Text] [Related]
2. Low diastolic pressure and risk of dementia in very old people: a longitudinal study.
Qiu C; Winblad B; Fratiglioni L
Dement Geriatr Cogn Disord; 2009; 28(3):213-9. PubMed ID: 19752556
[TBL] [Abstract][Full Text] [Related]
3. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure levels before dementia.
Petitti DB; Crooks VC; Buckwalter JG; Chiu V
Arch Neurol; 2005 Jan; 62(1):112-6. PubMed ID: 15642857
[TBL] [Abstract][Full Text] [Related]
5. High systolic and pulse pressure levels are associated with better cognitive performance in patients with probable Alzheimer's disease: a cross-sectional observational study in a geriatric outpatient population.
van Bruchem-Visser RL; Mattace-Raso FU; van der Cammen TJ
Dement Geriatr Cogn Disord; 2009; 28(4):320-4. PubMed ID: 19844106
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment.
Schneider P; Buerger K; Teipel S; Uspenskaya O; Hartmann O; Hansson O; Minthon L; Rujescu D; Moeller HJ; Zetterberg H; Blennow K; Ernst A; Bergmann A; Hampel H
Biol Psychiatry; 2011 Jul; 70(2):145-51. PubMed ID: 21457948
[TBL] [Abstract][Full Text] [Related]
7. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
8. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging.
Kiefer C; Brockhaus L; Cattapan-Ludewig K; Ballinari P; Burren Y; Schroth G; Wiest R
Neuroimage; 2009 Dec; 48(4):657-67. PubMed ID: 19607926
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sex hormones, cognitive decline, and future dementia in old men.
Geerlings MI; Strozyk D; Masaki K; Remaley AT; Petrovitch H; Ross GW; White LR; Launer LJ
Ann Neurol; 2006 Sep; 60(3):346-55. PubMed ID: 16865684
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive treatments, cognitive decline, and dementia.
Duron E; Hanon O
J Alzheimers Dis; 2010; 20(3):903-14. PubMed ID: 20182022
[TBL] [Abstract][Full Text] [Related]
11. Hypertension and dementia.
Nagai M; Hoshide S; Kario K
Am J Hypertens; 2010 Feb; 23(2):116-24. PubMed ID: 19927134
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
[TBL] [Abstract][Full Text] [Related]
13. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.
Hsiung GY; Alipour S; Jacova C; Grand J; Gauthier S; Black SE; Bouchard RW; Kertesz A; Loy-English I; Hogan DB; Rockwood K; Feldman HH
Dement Geriatr Cogn Disord; 2008; 25(6):483-90. PubMed ID: 18417973
[TBL] [Abstract][Full Text] [Related]
14. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
Shah RC; Wilson RS; Bienias JL; Arvanitakis Z; Evans DA; Bennett DA
Neuroepidemiology; 2006; 26(1):30-6. PubMed ID: 16254451
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
Athey RJ; Walker RW
Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
[TBL] [Abstract][Full Text] [Related]
16. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and cognitive function.
Paglieri C; Bisbocci D; Caserta M; Rabbia F; Bertello C; Canadè A; Veglio F
Clin Exp Hypertens; 2008 Nov; 30(8):701-10. PubMed ID: 19021021
[TBL] [Abstract][Full Text] [Related]
18. Low sleep efficiency in patients with cognitive impairment.
Yu JM; Tseng IJ; Yuan RY; Sheu JJ; Liu HC; Hu CJ
Acta Neurol Taiwan; 2009 Jun; 18(2):91-7. PubMed ID: 19673360
[TBL] [Abstract][Full Text] [Related]
19. Trajectory of mild cognitive impairment onset.
Howieson DB; Carlson NE; Moore MM; Wasserman D; Abendroth CD; Payne-Murphy J; Kaye JA
J Int Neuropsychol Soc; 2008 Mar; 14(2):192-8. PubMed ID: 18282317
[TBL] [Abstract][Full Text] [Related]
20. Relation of cognitive activity to risk of developing Alzheimer disease.
Wilson RS; Scherr PA; Schneider JA; Tang Y; Bennett DA
Neurology; 2007 Nov; 69(20):1911-20. PubMed ID: 17596582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
